Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]- anthracene

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5564-5570

  Böttinger, Erwin P ^a,c   Jakubczak, John L ^a   Haines, Diana C ^b   Bagnall, Kerri ^a   Wakefield, Lalage M ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d Laboratory of Chemoprevention   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; COCARCINOGENESIS; FEMALE; GENE EXPRESSION; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 0031441041     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Roberts, A. B., and Sporn, M. B. The transforming growth factors-β. In: M. B. Sporn and A. B. Roberts (eds.), Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, Vol. 95, pp. 419-472. Berlin: Springer-Verlag, 1990.
2. Park, K., Kim, S-J., Bang, Y-J., Park, J. G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor-β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
3. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Slun, L., Lutterbaugh, L., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
4. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S., Gesmonde, J., Vellucci, V., and Reiss, M. Missense mutations of the transforming growth factor-β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
5. Damstrup, L., Rygaard, K., Spang-Thomsen, M., and Poulson, H. S. Expression of transforming growth factor beta (TGF-β) receptors and expression of TGF-β1, TGF-β2 and TGF-β3 in human small cell lung cancer cell lines. Br. J. Cancer, 67: 1015-1021, 1993.
6. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J-H., Kato, M., and Lee, C. Genetic change in transforming growth factor-β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
7. Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
8. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
9. Markowitz, S. D., and Roberts, A. B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev., 7: 93-102, 1996.
10. Wang, J., Sun, E., Myeroff, L., Wang, X., Gentry, L. E., Yang, L., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K., and Brattain, M. G. Demonstration that mutation of the type II TGF-β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
11. Sun, E., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., and Brattain, M. G. Expression of transforming growth factor-β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269: 26449-26455, 1994.
12. Wu, S., Theodorescu, D., Kerbel, R. S., Willson, J. K. V., Mulder, K. M., Humphrey, L. E., and Brattain, M. G. TGF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol., 116: 187-196, 1992.
13. Hosobuchi, M., and Stampfer, M. R. Effects of transforming growth factor-β on growth of human mammary epithelial cells in culture. In Vitro Cell. Dev. Biol., 25: 705-713, 1989.
14. Silberstein, G. B., and Daniel, C. W. Reversible inhibition of mammary gland growth by transforming growth factor-β. Science (Washington DC), 237: 291-293, 1987.
15. Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Hennighausen, L., Roberts, A. B., Smith, G. H., and Merlino, G. Targeting expression of a transforming growth factor-β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J., 12: 1835-1845, 1993.
16. Pierce, D. F., Jr., Johnson, M. D., Matsui, Y., Robinson, S. D., Gold, L. I., Purchio, A. F., Daniel, C. W., Hogan, B. L. M., and Moses, H. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev., 7: 2308-2317, 1993.
17. Pierce, D. F., Jr., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., Jr., and Moses, H. L. Mammary tumor suppression by transforming growth factor-β1 transgene expression. Proc. Natl. Acad. Sci. USA, 92: 4254-4258, 1995.
18. Robinson, S. D., Silberstein, G. B., Roberts, A. B., Flanders, K. C., and Daniel, C. W. Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development. Development (Camb.), 113: 867-878, 1991.
19. Arteaga, C. L., Tandon, A. K., Von Hoff, D. D., and Osbome, C. K. Transforming growth factor-β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48: 3898-3904, 1988.
20. Younes, M., Fernandez, L., Laucinca, R. Transforming growth factor-β receptor II (TGF-β-RII) is infrequently expressed in human breast cancer. Breast J., 2: 150-153, 1996.
21. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 169: 669-671, 1994.
22. Bonham, M. J., and Danielpour, D. Improved purification and yields by RNeasy. Biotechniques. 21: 57-60, 1996.
23. Frolik, C. A., Wakefield, E. M., Smith, D. M., and Sporn, M. B. Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J. Biol. Chem., 259: 10995-11000, 1984.
24. Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B., and Sporn, M. B. Inhibition of growth by transforming growth factor-β following fusion of two non-responsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J. Biol. Chem., 267: 2583-2588, 1992.
25. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B., and Sporn, M. B. Immunodetection and quantitation of two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells. J. Cell Physiol., 138: 79-86, 1989.
26. Wigler, M., Pellicer, A., Silverstein, S., Axel, R., Urlaub, G., and Chasin, L. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. USA, 76: 1373-1376, 1979.
27. van Zonneveld, A-J., Curriden, S. A., and Loskutoff, D. J. Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. USA, 85: 5525-5529, 1988.
28. Massagué, J., The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
29. Chen, R-H., Ebner, R., and Derynck, R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science (Washington DC), 260: 1335-1338, 1993.
30. Böttinger, E. P., Jakubczak, J. L., Roberts, I. S. D., Mumy, M., Hemmati, P., Bagnall, K., Merlino, G., and Wakefield, L. M. Expression of a dominant-negative mutant TGF-β receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas. EMBO J., 16: 2621-2633, 1997.
31. Weiser, R., Attisano, L., Wrana, J. L., and Massagué, J. Signaling activity of transforming growth factor-β type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol., 13: 7239-7247, 1993.
32. Hennighausen, L., Wall, R. J., Tillmann, U., Li, M., and Furth, P. A. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J. Cell. Biochem., 59: 1-10, 1995.
33. Coffey, R. J., Jr., Meise, K. S., Matsui, Y., Hogan, B. L. M., Dempsey, P. J., and Halter, S. A. Acceleration of mammary neoplasia in transforming growth factor-alpha transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res., 54: 1678-1683, 1994.
34. Medina, D. Serial transplantation of chemical carcinogen-induced mouse mammary ductal hyperplasias. J. Natl. Cancer Inst., 62: 397-405, 1979.
35. Oshima, M., Oshima, H., and Taketo, M. M. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol., 179: 297-302, 1996.
36. Wang, X-J., Greenhalgh, D. A., Bickenbach, J. R., Jiang, A., Bundman, D. S. Krieg, T., Derynck, R., and Roop, D. R. Expression of a dominant-negative type II transforming growth factor-β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition. Proc. Natl. Acad. Sci. USA, 94: 2386-2391, 1997.
37. Kordon, E. C., McKnight, R. A., Jhappan, C., Hennighausen, L., Merlino, G., and Smith, G. Ectopic TGF-β1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev. Biol., 167: 47-61, 1995.
38. Stewart, T. A., Pattengale, P. K., and Leder, P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell, 38: 627-637.
39. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1988.
40. Jhappan, C., Gallahan, D., Stahle, C., Chu, E., Smith, G. H., Merlino, G., and Callahan, R. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev., 6: 345-355, 1992.
41. Liu, Q. Y., Jiranjan, B., Gomes, P., Gomm, J. J., Davies, D., Coombes, R. C., and Buluwela, L. Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res., 56: 1155-1163, 1996.
42. Huynh, H. T., Larsson, C., Narod, S., and Pollak, M. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res., 55: 2225-2231, 1995.
43. Taketo, M., Schroeder, A. C., Mobraaten, L. E., Gunning, K. B., Hanten, G., Fox, R. R., Roderick, T. H., Stewart, C. L., Lilly. F., Hansen, C. T., and Overbeek, P. A. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. USA, 88: 2065-2069, 1991.
44. Li, B., Kittrell, F. S., Medina, D., and Rosen, J. M. Delay of dimethylbenz[a|anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein. Mol. Carcinog., 14: 75-83, 1995.
45. Kito, K., Kihana, T., Sugita, A., Murao, S., Akehi, S., Sato, M., Tachibana, M., Kimura, S., and Ueda, N. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary tumors. Mol. Carcinog., 17: 78-83, 1996.
46. Glick, A. B., Lee, M. M., Darwiche, N., Kulkarni, A. B., Karlsson, S., and Yuspa, S. H. Targeted deletion of the TGF-β gene causes rapid progression to squamous cell carcinoma. Genes Dev., 8: 2429-2440, 1994.
47. Wu, S. P., Sun, L-Z., Willson, J. K. V., Humphrey, L., Kerbel, R., and Brattain, M. G. Repression of autocrine transforming growth factor-β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ., 4: 115-123, 1993.
48. Glick, A. B., Weinberg, W. C., Wu, I-H., Quan, W., and Yuspa, S. H. Transforming growth factor β1 suppresses genomic instability independent of G1 arrest, p53 and Rb. Cancer Res., 56: 3645-3650, 1996.